Search research articles
Contact Us
Filters
Showing results (261-270 of 287) with videos related to
Page
of 29
Sort By:
Pediatric Blood & Cancer
|
January 19, 2017
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement
Jamie E Flerlage, Kara M Kelly, Auke Beishuizen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 23, 2022
Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma
Omran Saifi, William G Breen, Scott C Lester, et al.
Haematologica
|
June 15, 2023
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma
Omran Saifi, William G Breen, Scott C Lester, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 26, 2017
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee
Yolanda D Tseng, David J Cutter, John P Plastaras, et al.
British Journal of Haematology
|
January 14, 2026
Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL Group
S Claire Gowdy, Jamie E Flerlage, Jennifer Seelisch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 31, 2026
Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions
Jessica F Burlile, William S Harmsen, Sydney D Suddendorf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 19, 2026
Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report from the National Clinical Trials Network
N Kovalchuk, E Simiele, M LaRiviere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826
Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Blood Advances
|
July 19, 2024
Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy
Omran Saifi, William G Breen, Scott C Lester, et al.
Blood Advances
|
January 11, 2024
Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy
Jessica F Burlile, Kelsey M Frechette, William G Breen, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 287) with videos related to
Sort By:
Page
of 29
Pediatric Blood & Cancer
|
January 19, 2017
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement
Jamie E Flerlage, Kara M Kelly, Auke Beishuizen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 23, 2022
Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma
Omran Saifi, William G Breen, Scott C Lester, et al.
Haematologica
|
June 15, 2023
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma
Omran Saifi, William G Breen, Scott C Lester, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 26, 2017
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee
Yolanda D Tseng, David J Cutter, John P Plastaras, et al.
British Journal of Haematology
|
January 14, 2026
Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL Group
S Claire Gowdy, Jamie E Flerlage, Jennifer Seelisch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 31, 2026
Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions
Jessica F Burlile, William S Harmsen, Sydney D Suddendorf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 19, 2026
Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report from the National Clinical Trials Network
N Kovalchuk, E Simiele, M LaRiviere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826
Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Blood Advances
|
July 19, 2024
Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy
Omran Saifi, William G Breen, Scott C Lester, et al.
Blood Advances
|
January 11, 2024
Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy
Jessica F Burlile, Kelsey M Frechette, William G Breen, et al.
Page
of 29